Chemotherapy combined with bevacizumab for the treatment of advanced lung adenocarcinoma cancer harboring EGFR‐ANXA2, EGFR‐RAD51, ATR and BRCA2 mutations: A case report

Here, we report a case of a 36‐year‐old female patient with metastatic non‐small cell lung cancer (NSCLC) harboring EGFR‐ANXA2 and EGFR‐RAD51 double fusion mutations with BRCA2 (nonsense mutation of exon 11) and ATR mutations (Exon 44 variable shear mutation) identified by next generation sequencing...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Rui, Li, Hui, Liu, Yanling, Zhang, Shuang, Liu, Jingjing, Huang, Zhicheng, Cheng, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997000/
https://www.ncbi.nlm.nih.gov/pubmed/31865638
http://dx.doi.org/10.1111/1759-7714.13286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997000/
https://www.ncbi.nlm.nih.gov/pubmed/31865638
http://dx.doi.org/10.1111/1759-7714.13286

Ejemplares similares